NCT00122746Unknown3 期
Doctoral CRP on Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 322
- 试验地点
- 5
- 主要终点
- 3 year recurrence free survival
研究概览
简要总结
The researchers plan:
- To undertake clinical studies of radiotherapy with or without the administration of the chemotherapeutic agent cisplatin, known to be a radiosensitizer;
- To perform pre-clinical studies of the radiosensitivity of human fibroblasts and cervical cancer cell lines in culture, with or without the addition of various HIV proteins or protease inhibitors, in order to determine the extent of any cellular radiosensitizing properties of these molecules;
- To develop strategies for sensitizing tumour cells to radiation, specifically by down-regulating specific viral proteins that are known to be factors associated with resistance to radiotherapy.
详细描述
Clinical study addresses the question of whether radiotherapy plus weekly cisplatin offers an advantage over the same radiotherapy given alone in AIDS patients with cervix cancer. External beam radiotherapy is used with 50 Gy in 25 daily fractions (last interim analysis, October 2005) suggested lowering the total dose down to 46 Gy in 23 daily fractions). Brachytherapy component was specified as either 30 Gy of LDR in a single fraction or 3 fractions of 8 Gy using HDR. Cisplatin was administered weekly at a dose of 30 mg/sqm.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Cancer of the cervix
排除标准
- •Unable to give informed consent
结局指标
主要结局
3 year recurrence free survival
时间窗: 3 years
次要结局
- Incidence of Grade 3 acute toxicity(3 months)
- Pelvic control rates(3 years)
- Tumour response at 3 months.(3 months)
- Cancer specific survival rates.(3 years)
- Overall survival rates.(3 years)
- Acute and late toxicities after the treatment.(up to 3 years)
研究者
研究点 (5)
Loading locations...
相似试验
Unknown
不适用
Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast ReconstructionBreast CancerNCT03072316Royal Marsden NHS Foundation Trust300
尚未招募
不适用
A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and ChemotherapyNasopharyngeal CarcinomaNCT05622474Sun Yat-sen University236
招募中
不适用
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular CarcinomaStage IIIA Hepatocellular CarcinomaNCT06061445Fujian Cancer Hospital22
Unknown
2 期
Planned Non-operative Management for Rectal CancerRectal CancerNCT05241574Maria Sklodowska-Curie National Research Institute of Oncology23
招募中
不适用
MRI Development for Radiotherapy Planning and Delivery in Non-Patient VolunteersFocus of the Study is MRI Sequence DevelopmentNCT04749134The Christie NHS Foundation Trust500